Physician profile
Brian Yang
NPI 1962441592
$1,238.96
in general payments reported to CMS, 2019-2025
13 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $40.28 · 2023: $704 · 2024: $143 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $114.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $607.19 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acumed LLC | $125.00 | 2024 | Acumed |
| Intuitive Surgical, INC. | $122.34 | 2025 | |
| Straumann USA LLC | $114.23 | 2023 | |
| Novo Nordisk INC | $85.08 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.19 | 2019 | |
| Boston Scientific Corporation | $26.89 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $26.41 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $22.06 | 2019 | |
| Astellas Pharma US INC | $21.76 | 2019 | |
| Merck Sharp & Dohme LLC | $19.17 | 2019 | |
| Avanir Pharmaceuticals, INC. | $17.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.